Seeking Alpha
About this author:
Submit
an article to

When I first responded to a reader inquiry about YM BioSciences (YMI) a few weeks ago, I called it a nice mid to long term speculative play that could quickly resume trading for over a dollar as speculative money starts coming back into the market.

The trip to over a buck was a quick one, as YMI spiked to over $1.70 during early trading on Wednesday, making many sub-$1 investors extremely happy.

I stand by my previous assessment that YMI is good speculative play, but I'd be a little bit more careful about getting in now, after the nice run, than before when I considered it a great buy for about sixty cents.

As long as the market holds up, this stock should be above a dollar for good and I'd treat it like Keryx Biopharmaceuticals (KERX) - buy the dips. If positive news is released to support the recent run, then the stock could be done trading for below $2, but if the run is just a case of YM trading to its potential, then dips to the low $1 range are likely and that would be a perfect time to add more shares.

I considered moving my EpiCept (EPCT) money into YMI earlier this month, but I never got around to doing that. Too bad, on my part - I missed the boat!

There's a lot of potential loaded into this stock.

Disclosure: No positions.

Print this article with comments
Comments
3
Comments 1 - 3 out of 3
You are viewing the latest 20 comments
  •  
    Oh well don't fee lso bad, I got in around .50c but didn't load the boat, still holding, I plan to load-up if she dips down again...
    Aug 27 09:06 AM | Link | Reply
  •  
    What I find intriguing is the Cuba connection. What other compounds have they produced, and what other (presumably) Canadian companies have agreements? Could be lots of potential, now that the door is ajar.
    Aug 27 10:58 AM | Link | Reply
  •  
    Thanks for the comments.

    YMI could be a nice one.

    Good on you guys, sorry I missed the boat, but I'll buy on any significant dips from here on out.

    VFC
    Aug 28 12:55 AM | Link | Reply
Viewing Comments 1-3 out of 3